SCHEMBL703035

SCHEMBL703035

CCC([SiH2]OC(C)C)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.34
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GRIN1 Q05586 6/20 0.32
GRIN2A Q12879 6/20 0.32
GRIN2D O15399 5/20 0.32
GRIN2C Q14957 5/20 0.32
GRIN2B Q13224 4/20 0.32
TAAR1 Q96RJ0 1/20 0.31
ALOX15 P16050 1/20 0.31
OPRM1 P35372 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
KIF11 P52732 1/20 0.31
KDM4E B2RXH2 1/20 0.31
CACNA1F O60840 1/20 0.31
ABCB1 P08183 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6906459 0.77 KIF11 (0.30) KIF11
SCHEMBL713410 0.77 MAPK1 (0.40) KCNN4MAPK1ALDH1A1CYP2C19TAAR1
SCHEMBL704362 0.75 MAPK1 (0.41) KCNN4MAPK1ALDH1A1CYP2D6CYP2C19
SCHEMBL707772 0.71 KCNN4 (0.38) KCNN4ALDH1A1CYP2C19GRIN1GRIN2A
Biphenyl SCHEMBL27660701 0.71 PDCD1 (0.39) MAPK1ALDH1A1CYP2C19KIF11GAA
SCHEMBL704484 0.70 KCNN4 (0.40) KCNN4MAPK1ALDH1A1CYP2C19TAAR1
SCHEMBL4620006 0.70 KCNN4 (0.40) KCNN4MAPK1ALDH1A1CYP2C19TAAR1
SCHEMBL707329 0.70 KCNN4 (0.45) KCNN4MAPK1ALDH1A1CYP2C19TAAR1
SCHEMBL705992 0.70 CYP2C19 (0.42) KCNN4MAPK1ALDH1A1CYP2C19TAAR1
Biphenyl SCHEMBL1228336 0.65 ALDH1A1 (0.45) MAPK1ALDH1A1CYP2C19TAAR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465670-B2 SURFACE TREATMENT USING ORGANOSILICON COMPOUND, SOLVENT AND PHASE TRANSFER CATALYST THE GOODYEAR TIRE & RUBBER COMPANY 2002-10-15 US claimed
US-20020022085-A1 Preparation of surface modified silica GOODYEAR TIRE & RUBBER COMPANY, THE 2002-02-21 US claimed
US-8124239-B2 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2012-02-28 US disclosed
US-20100155121-A1 SILICA FILM FORMING MATERIAL, SILICA FILM AND METHOD OF MANUFACTURING THE SAME, MULTILAYER WIRING STRUCTURE AND METHOD OF MANUFACTURING THE SAME, AND SEMICONDUCTOR DEVICE AND METHOD OF MANUFACTURING THE SAME FUJITSU LIMITED (JP) 2010-06-24 US disclosed
US-7659357-B2 Precursor organosilicon polymer of 1,2-Bis(dimethylethoxysilyl)ethane, 1,4-bis(dimethylethoxysilyl)benzene, tetraethoxysilane, methyltriethoxysilane, phenyltriethoxysilane; dielectric (DE) films having etching/chemical/moisture resistance; adhesion; low DE constant; minimal wiring delay; high speed FUJITSU LIMITED (JP) 2010-02-09 US disclosed
US-20070026689-A1 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2007-02-01 US disclosed
EP-1178077-B1 The preparation of surface modified silica GOODYEAR TIRE & RUBBER (US) 2004-06-16 EP disclosed
US-6465670-B2 SURFACE TREATMENT USING ORGANOSILICON COMPOUND, SOLVENT AND PHASE TRANSFER CATALYST THE GOODYEAR TIRE & RUBBER COMPANY 2002-10-15 US disclosed
US-20020022085-A1 Preparation of surface modified silica GOODYEAR TIRE & RUBBER COMPANY, THE 2002-02-21 US disclosed
EP-1178077-A1 The preparation of surface modified silica THE GOODYEAR TIRE & RUBBER COMPANY (US) 2002-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020022085-A1 Preparation of surface modified silica OSTC, SAMM50, SSRP1 KCNN4 3648/4885MAPK1 3521/4885ALDH1A1 3796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.